| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| CymaBay Therapeutics, Inc. | Chief Commercial Officer | Employee Stock Option (right to buy) | 215,000 | 25 Jan 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000106299323001490-stuart-lewis-j-2023-01-25 | CymaBay Therapeutics, Inc. | 25 Jan 2023 | 1 | $0 | 4 | Chief Commercial Officer | 27 Jan 2023, 15:26 |
| /report/000106299322001700-stuart-lewis-j-2022-01-25 | CymaBay Therapeutics, Inc. | 25 Jan 2022 | 1 | $0 | 4 | Chief Commercial Officer | 27 Jan 2022, 15:56 |
| /report/000106299321004321-stuart-lewis-j-2021-05-10 | CymaBay Therapeutics, Inc. | 10 May 2021 | 1 | $0 | 4 | Chief Commercial Officer | 10 May 2021, 17:55 |
| /report/000106299321004318-stuart-lewis-j-2021-05-10 | CymaBay Therapeutics, Inc. | 10 May 2021 | 0 | $0 | 3 | Chief Commercial Officer | 10 May 2021, 17:47 |